The report highlights that smoke and pollution emitted by vehicles on the Pune-Mumbai Expressway—one of western India's ...

The water has been classified under Class E, with a dissolved oxygen value of 2.3mg/L and a total coliform bacteria level at ...

We recently published a list of the 11 Best Penny Stocks to Invest in Under $1. In this article, we are going to take a look ...

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

A retrospective analysis from Israel suggested that markers of poor hydration are linked to increased risks of hypertension ...

Late-breaking oral presentation to include full Phase 1b results for TX45 in the Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) cohortWATERTOWN, Mass., ...

Keros Therapeutics halted phase 2 of TROPOS, but KER-065 shows promise in DMD and financial stability ensures growth ...

Treatments approved for PAH may reduce by half the risk of serious complications or death in patients with repaired ...

DelveInsight's "TIBSOVO Market Size, Forecast, and Market Insight Report" highlights the details around TIBSOVO, the first and only targeted therapy approved for patients with previously treated ...

In April 2025, Actelion announced a study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the ...

Biotech Analyst Kim holds a conference call with Dr. Sullivan, Chief Product Strategy Officer, to discuss INSM‘s TPIP (Treprostinil Palmitil ...